Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis

被引：0
|
作者：
Bernard Combe
Robin Besuyen
Antonio Gómez-Centeno
Tsukasa Matsubara
Juan José Sancho Jimenez
Zhaoyu Yin
Maya H. Buch
机构：
[1] University of Montpellier,NIHR Manchester Biomedical Research Centre
[2] Galapagos BV,undefined
[3] Hospital Universitari Parc Tauli,undefined
[4] Sabadell,undefined
[5] Matsubara Mayflower Hospital,undefined
[6] Galapagos,undefined
[7] Gilead Sciences,undefined
[8] Inc.,undefined
[9] University of Manchester,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Adverse effects; Disease-modifying antirheumatic drug; Filgotinib; Outcomes; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Clinical trials in rheumatoid arthritis recruit too few patients from diverse ethnic backgrounds to be able to identify differences in treatment outcomes. In adults with moderate-to-severe active rheumatoid arthritis who do not tolerate or have responded poorly to other advanced treatments, the Janus kinase inhibitor filgotinib can be used alone or in combination with the immunosuppressant methotrexate. Using data from 4695 patients with rheumatoid arthritis from five previous clinical trials and two ongoing trial extensions, this paper examined the efficacy and safety of filgotinib in patients with rheumatoid arthritis across geographic locations worldwide.
引用
收藏
页码：35 / 51
页数：16
相关论文
共 50 条
  • [41] Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives
    Tanaka, Yoshiya
    Genovese, Mark C.
    Matsushima, Hironori
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 2499 - 2516
  • [42] Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis Naive to Methotrexate Therapy: FINCH3 Primary Outcome Results
    Westhovens, Rene
    Rigby, William F. C.
    van der Heijde, Desiree
    Ching, Daniel W. T.
    Bartok, Beatrix
    Matzkies, Franziska
    Yin, Zhaoyu
    Guo, Ying
    Tasset, Chantal
    Sundy, John
    Arian, Neelufar Mozaff
    Messina, Osvaldo Daniel
    Landewe, Robert B. M.
    Atsumi, Tatsuya
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [43] The efficacy and safety of tacrolimus in rheumatoid arthritis
    Dutta, Shouma
    Ahmad, Yasmeen
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2011, 3 (06) : 283 - 291
  • [44] Efficacy and safety of peficitinib in rheumatoid arthritis
    Kaneko, Yuko
    MODERN RHEUMATOLOGY, 2020, 30 (05) : 773 - 778
  • [45] A BUDGET IMPACT ANALYSIS OF INTRODUCING FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN GREECE
    Nomikos, N.
    Naoum, P.
    Athanasakis, K.
    Kyriopoulos, I
    VALUE IN HEALTH, 2024, 27 (12)
  • [46] HERPES ZOSTER IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM
    Winthrop, K.
    Buch, M. H.
    Curtis, J.
    Burmester, G. R.
    Aletaha, D.
    Amano, K.
    Pechonkina, A.
    Tiamiyu, I.
    Leatherwood, C.
    Ye, L.
    Gong, Q.
    Besuyen, R.
    Galloway, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 255 - 256
  • [47] Integrated Safety Analysis of Filgotinib in Patients with Moderate to Severe Active Rheumatoid Arthritis with a Maximum Exposure of 8.3 Years
    Withrop, Kevin
    Aletaha, Daniel
    Caporali, Roberto F.
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Van Hoek, Paul
    Stiers, Pieter-Jan
    Rajendran, Vijay
    Van Beneden, Katrien
    Gottenberg, Jacques-Eric
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2596 - 2598
  • [48] POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Bartok, Beatrix
    Winthrop, Kevin L.
    Genovese, Mark
    Combe, Bernard G.
    Tanaka, Yoshiya
    Kivitz, Alan
    Matzkies, Franziska
    Ye, Lei
    Guo, Ying
    Tasset, Chantal T.
    Sundy, John S.
    Keystone, Edward
    Westhovens, Rene
    Rigby, William
    Burmester, Gerd R.
    Walker, David R.
    GASTROENTEROLOGY, 2020, 158 (06) : S679 - S679
  • [49] SAFETY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANALYSIS OF LYMPHOCYTES IN THE LONG-TERM EXTENSION FINCH 4 STUDY
    Gottenberg, J. E.
    Burmester, G. R.
    Van Beneden, K.
    Watson, C.
    Seghers, I.
    Rajendran, V.
    Dagna, L.
    Buch, M. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 512 - 513
  • [50] Filgotinib in Rheumatoid Arthritis: A Profile of Its Use
    Esther S. Kim
    Susan J. Keam
    Clinical Drug Investigation, 2021, 41 : 741 - 749
12345